Home » Topics » BioWorld Science

BioWorld Science
RSS

IVAX receives approval for generic antihypertensive drug

Sep. 13, 1996

Warner-Lambert focuses on endothelin antagonists

Sep. 13, 1996

Merck & Co. describes endothelin antagonists

Sep. 13, 1996

Selective dual inhibitor of PDE I and PDE V from Schering-Plough

Sep. 13, 1996

C5a receptor required for host defense in the lung

Sep. 13, 1996

Potential antiasthmatic agent from Lipha

Sep. 13, 1996

Novel PAF and 5-LO inhibitors reported by Sunkyong

Sep. 13, 1996

Improved agents for asthma

Sep. 13, 1996

Progress in CNS drug development at Daiichi

Sep. 13, 1996

Chugai's CNS pipeline

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...